IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19

29Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The more severe phenotype of mice lacking CD19 as compared to CD21 suggests that a complement-independent ligand for the CD19/CD21 complex exists. We sought ligands for CD19 by examining binding reactions with fusion proteins comprised of the extracellular region of CD19 and the Fc region of IgG1. A fusion protein containing the third extracellular domain (D3-Fc) bound to WEHI-231 cells, and this was competed by soluble IgM. This function of IgM was confirmed by the binding of D3-Fc to beads coated with IgM. A second ligand for D3-Fc was found on stromal cells, and was shown to be heparin/heparan sulfate. These two ligands would be considered to reside on follicular dendritic cells, and may account for the observed ability of D3-Fc to bind to sites in germinal centers containing these cells.

Author supplied keywords

Cite

CITATION STYLE

APA

De Fougerolles, A. R., Batista, F., Johnsson, E., & Fearon, D. T. (2001). IgM and stromal cell-associated heparan sulfate/heparin as complement-independent ligands for CD19. European Journal of Immunology, 31(7), 2189–2199. https://doi.org/10.1002/1521-4141(200107)31:7<2189::AID-IMMU2189>3.0.CO;2-V

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free